Logo image of MBOT

MICROBOT MEDICAL INC (MBOT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MBOT - US59503A2042 - Common Stock

2.095 USD
-0.06 (-3.01%)
Last: 1/15/2026, 3:53:06 PM
Fundamental Rating

3

MBOT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for MBOT as it has an excellent financial health rating, but there are worries on the profitability. MBOT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year MBOT has reported negative net income.
  • MBOT had a negative operating cash flow in the past year.
  • MBOT had negative earnings in each of the past 5 years.
  • In the past 5 years MBOT always reported negative operating cash flow.
MBOT Yearly Net Income VS EBIT VS OCF VS FCFMBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • MBOT has a Return On Assets of -15.99%. This is comparable to the rest of the industry: MBOT outperforms 55.68% of its industry peers.
  • MBOT's Return On Equity of -16.71% is fine compared to the rest of the industry. MBOT outperforms 61.62% of its industry peers.
Industry RankSector Rank
ROA -15.99%
ROE -16.71%
ROIC N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
MBOT Yearly ROA, ROE, ROICMBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MBOT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBOT Yearly Profit, Operating, Gross MarginsMBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

  • The number of shares outstanding for MBOT has been increased compared to 1 year ago.
  • Compared to 5 years ago, MBOT has more shares outstanding
  • MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBOT Yearly Shares OutstandingMBOT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MBOT Yearly Total Debt VS Total AssetsMBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 23.47 indicates that MBOT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 23.47, MBOT belongs to the best of the industry, outperforming 96.76% of the companies in the same industry.
  • MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.47
ROIC/WACCN/A
WACCN/A
MBOT Yearly LT Debt VS Equity VS FCFMBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • MBOT has a Current Ratio of 27.53. This indicates that MBOT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 27.53, MBOT belongs to the best of the industry, outperforming 98.92% of the companies in the same industry.
  • A Quick Ratio of 27.53 indicates that MBOT has no problem at all paying its short term obligations.
  • The Quick ratio of MBOT (27.53) is better than 98.92% of its industry peers.
Industry RankSector Rank
Current Ratio 27.53
Quick Ratio 27.53
MBOT Yearly Current Assets VS Current LiabilitesMBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 35.21% over the past year.
EPS 1Y (TTM)35.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 14.39% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y57.96%
EPS Next 2Y23.75%
EPS Next 3Y15.61%
EPS Next 5Y14.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MBOT Yearly Revenue VS EstimatesMBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2025 2026 2027 2029 10M 20M 30M
MBOT Yearly EPS VS EstimatesMBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 -200 -400 -600

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • MBOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MBOT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBOT Price Earnings VS Forward Price EarningsMBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBOT Per share dataMBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • MBOT's earnings are expected to grow with 15.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.75%
EPS Next 3Y15.61%

More info and screens

0

5. Dividend

5.1 Amount

  • MBOT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

MICROBOT MEDICAL INC

NASDAQ:MBOT (1/15/2026, 3:53:06 PM)

2.095

-0.06 (-3.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-23
Inst Owners13.84%
Inst Owner Change0%
Ins Owners1.47%
Ins Owner Change0%
Market Cap140.70M
Revenue(TTM)N/A
Net Income(TTM)-13.07M
Analysts82.5
Price Target7.65 (265.16%)
Short Float %9.56%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.46%
Min EPS beat(2)-22.55%
Max EPS beat(2)-14.38%
EPS beat(4)1
Avg EPS beat(4)-3.43%
Min EPS beat(4)-22.55%
Max EPS beat(4)32.13%
EPS beat(8)4
Avg EPS beat(8)1.02%
EPS beat(12)8
Avg EPS beat(12)6.9%
EPS beat(16)9
Avg EPS beat(16)2.11%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.29%
PT rev (3m)-37.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.75%
EPS NY rev (1m)1.61%
EPS NY rev (3m)10.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-85%
Revenue NY rev (1m)-50%
Revenue NY rev (3m)-90.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.8
P/tB 1.8
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0
BVpS1.16
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.99%
ROE -16.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 27.53
Quick Ratio 27.53
Altman-Z 23.47
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)46.2%
Cap/Depr(5y)70.94%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65%
EPS Next Y57.96%
EPS Next 2Y23.75%
EPS Next 3Y15.61%
EPS Next 5Y14.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-33.68%
EBIT Next 3Y-26.74%
EBIT Next 5Y12.42%
FCF growth 1Y-19.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.73%
OCF growth 3YN/A
OCF growth 5YN/A

MICROBOT MEDICAL INC / MBOT FAQ

What is the ChartMill fundamental rating of MICROBOT MEDICAL INC (MBOT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MBOT.


Can you provide the valuation status for MICROBOT MEDICAL INC?

ChartMill assigns a valuation rating of 0 / 10 to MICROBOT MEDICAL INC (MBOT). This can be considered as Overvalued.


How profitable is MICROBOT MEDICAL INC (MBOT) stock?

MICROBOT MEDICAL INC (MBOT) has a profitability rating of 1 / 10.


What is the financial health of MICROBOT MEDICAL INC (MBOT) stock?

The financial health rating of MICROBOT MEDICAL INC (MBOT) is 8 / 10.